Testosterone effective treatment for low libido in postmenopausal women

An international study showed testosterone, when used with no other hormone therapy, is an effective treatment for low libido in postmenopausal women.

More than 800 women from 65 centers in the United States, Canada, Australia, the United Kingdom and Sweden participated in the study, the first to show that testosterone administered by a skin patch can boost sex drive in postmenopausal women.

Previous studies have shown testosterone treatment for low libido is beneficial for women undergoing estrogen therapy. However, this study shows testosterone by itself could be a good alternative for women who do not want to take estrogen.

WHO:
Glenn Braunstein, M.D., chairman of the Department of Medicine at Cedars-Sinai Medical Center, is a primary investigator of the study and a co-author of an article in the New England Journal of Medicine. He is an expert in endocrinology, diabetes and metabolism, with a major research focus on androgen physiology in women and androgen treatment of women.

WHEN:
The study will be published in the Nov. 6 issue of the New England Journal of Medicine . Dr. Braunstein is available for interviews by appointment.

DISCLOSURE:
The study was supported by funding from Proctor & Gamble Pharmaceuticals USA. Dr. Braunstein has previously served as a paid consultant for Proctor & Gamble and he reviewed this study data on behalf of the company.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New therapies and technologies provide hope for age-related fertility challenges